Skip to main content
. 2019 Aug 23;62(17):7788–7805. doi: 10.1021/acs.jmedchem.9b00582

Figure 4.

Figure 4

Crystal structures of compound 11 bound to PaTrmD (A; PDB 5ZHM) and compound 12 bound to MtbTrmD (B; PDB 5ZHK), respectively. The polypeptide chains are shown as cartoons, whereas the residues involved in inhibitor binding are shown as sticks. Ligands are shown as sticks with 2FoFc electron density maps (gray) contoured at 1.0σ. Potential interactions involved in inhibitor binding are indicated by broken lines (black, hydrogen bonds; green, hydrophobic contacts including stacking interactions).